| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

Rigel to Present at the Jefferies 2023 Global Healthcare Conference
By: PR Newswire Association LLC. - 31 May 2023Back to overview list

SOUTH SAN FRANCISCO, Calif., May 31, 2023 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that Raul Rodriguez, the company's president and chief executive officer, will present on Wednesday, June 7, 2023 at 2:30 p.m. ET at the Jefferies 2023 Global Healthcare Conference, being held June 7-9, 2023 in New York, NY.

To access the live and subsequent archived webcast, visit the Investor Relations section of the company's website at Please connect to Rigel's website prior to the start of the live webcast to allow for any software downloads.

About Rigel

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer. Founded in 1996, Rigel is based in South San Francisco, California. For more information on Rigel, the Company's marketed products and pipeline of potential products, visit

Contact for Investors & Media:


Rigel Pharmaceuticals, Inc.



David Rosen

Argot Partners


Rigel Pharmaceuticals Logo (PRNewsfoto/Rigel Pharmaceuticals, Inc.)


Cision View original content to download multimedia:

SOURCE Rigel Pharmaceuticals, Inc.

Related companies:Rigel Pharmaceuticals, Inc.
Copyright 2023 PR Newswire Association LLC. Back to overview list
to the top ↑